Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Veracyte
VCYT
$3.54B
| $4.04M | 0.01% |
725,740
-55,030
| -7% | -$340K |
|
1927
AptarGroup
ATR
$8.58B
| $4.03M | 0.01% |
44,893
+32,472
| +261% | +$2.86M |
|
|
FSCT
1928
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $4.03M | 0.01% |
124,291
+111,606
| +880% | +$3.49M |
|
1929
Community Trust Bancorp
CTBI
$1.39B
| $4.02M | 0.01% |
88,877
+84,321
| +1,851% | +$3.92M |
|
1930
Vanguard Total International Bond ETF
BNDX
$82.9B
| $4.01M | 0.01% |
73,189
-100,157
| -58% | -$5.43M |
|
|
SEI
1931
Solaris Energy Infrastructure
SEI
$3.44B
| $4M | 0.01% |
241,284
+180,387
| +296% | +$3.39M |
|
1932
Globalstar
GSAT
$10.6B
| $3.98M | 0.01% |
386,151
+20,108
| +5% | +$299K |
|
1933
Entravision Communication
EVC
$750M
| $3.97M | 0.01% |
844,022
-1,128,121
| -57% | -$7.29M |
|
1934
New Mountain Finance
NMFC
$717M
| $3.97M | 0.01% |
301,688
-161,672
| -35% | -$2.13M |
|
1935
Applied Industrial Technologies
AIT
$12.4B
| $3.96M | 0.01% |
54,258
-284,481
| -84% | -$20.4M |
|
1936
IDEX
IEX
$17B
| $3.95M | 0.01% |
27,747
+12,740
| +85% | +$1.78M |
|
|
UN
1937
CALL
DELISTED
Unilever NV New York Registry Shares
UN
| $3.95M | 0.01% |
+70,000
| New | +$3.85M |
|
1938
Altria Group
MO
$114B
| $3.92M | 0.01% |
62,984
-1,271,879
| -95% | -$84.2M |
|
|
FOMX
1939
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.92M | 0.01% |
763,296
+19,628
| +3% | +$118K |
|
1940
SPS Commerce
SPSC
$2.89B
| $3.91M | 0.01% |
121,970
-584,870
| -83% | -$16.5M |
|
1941
JELD-WEN Holding
JELD
$210M
| $3.9M | 0.01% |
127,313
-290,144
| -70% | -$10.5M |
|
|
DRNA
1942
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.9M | 0.01% |
407,530
+340,623
| +509% | +$3.67M |
|
1943
Alamo Group
ALG
$1.97B
| $3.9M | 0.01% |
35,444
+31,370
| +770% | +$3.55M |
|
1944
Federated Hermes
FHI
$4.86B
| $3.87M | 0.01% |
115,977
+104,699
| +928% | +$3.56M |
|
|
XOMA
1945
DELISTED
Xoma
XOMA
| $3.87M | 0.01% |
191,289
-5,470
| -3% | -$153K |
|
|
CONN
1946
DELISTED
Conn's Inc.
CONN
| $3.86M | 0.01% |
113,547
+35,128
| +45% | +$1.17M |
|
|
KERX
1947
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $3.85M | 0.01% |
+940,589
| New | +$4.38M |
|
|
CBIO
1948
Crescent Biopharma
CBIO
$634M
| $3.84M | 0.01% |
2,366
+2,234
| +1,692% | +$4.65M |
|
|
ESTE
1949
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $3.84M | 0.01% |
379,311
+34,483
| +10% | +$349K |
|
|
AKRX
1950
CALL
DELISTED
Akorn Inc
AKRX
| $3.84M | 0.01% |
+205,000
| New | +$5.56M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.